O

Oscotec Inc
KOSDAQ:039200

Watchlist Manager
Oscotec Inc
KOSDAQ:039200
Watchlist
Price: 24 300 KRW -0.61%
Market Cap: 929.4B KRW
Have any thoughts about
Oscotec Inc?
Write Note

Oscotec Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Oscotec Inc
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
O
Oscotec Inc
KOSDAQ:039200
Income from Continuing Operations
-â‚©8.4B
CAGR 3-Years
22%
CAGR 5-Years
-11%
CAGR 10-Years
-6%
Yuhan Corp
KRX:000100
Income from Continuing Operations
â‚©162.4B
CAGR 3-Years
12%
CAGR 5-Years
30%
CAGR 10-Years
5%
SK Biopharmaceuticals Co Ltd
KRX:326030
Income from Continuing Operations
-â‚©35.4B
CAGR 3-Years
48%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Income from Continuing Operations
â‚©181.6B
CAGR 3-Years
26%
CAGR 5-Years
34%
CAGR 10-Years
16%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Income from Continuing Operations
â‚©10.8B
CAGR 3-Years
167%
CAGR 5-Years
-11%
CAGR 10-Years
-1%
C
Celltrion Pharm Inc
KOSDAQ:068760
Income from Continuing Operations
â‚©16.5B
CAGR 3-Years
-26%
CAGR 5-Years
81%
CAGR 10-Years
16%
No Stocks Found

Oscotec Inc
Glance View

Market Cap
929.3B KRW
Industry
Pharmaceuticals

Oscotec, Inc. engages in the development, manufacture and sale of pharmaceutical products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2007-01-17. The firm operates its business through three divisions: new medicines division, functional material products division and dental bone graft division. Its new medicines division provides osteoporosis drugs, arthritis drugs and periodontal disease drugs. Its functional material products division provides functional materials and food used for promoting bone growth and periodontal health. Its dental bone graft division provides bone graft materials, membranes and centrifuges. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
25 074.66 KRW
Undervaluation 3%
Intrinsic Value
Price
O

See Also

What is Oscotec Inc's Income from Continuing Operations?
Income from Continuing Operations
-8.4B KRW

Based on the financial report for Sep 30, 2024, Oscotec Inc's Income from Continuing Operations amounts to -8.4B KRW.

What is Oscotec Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-6%

Over the last year, the Income from Continuing Operations growth was 59%. The average annual Income from Continuing Operations growth rates for Oscotec Inc have been 22% over the past three years , -11% over the past five years , and -6% over the past ten years .

Back to Top